In line with our Purpose and our Solvay One Planet sustainability program, we are committed to optimizing the use of our resources to reduce our impact on people and the environment. Our G.R.O.W. strategy is aligned with powerful global trends that drive growth in our end-markets. It builds on Solvay’s unique and diversified portfolio of technologies and its ability to innovate and develop sustainable solutions, using our Sustainable Portfolio Management (SPM) methodology.
Throughout the crisis, our business model has proved to be a key advantage and contributed, along with our balanced end-markets exposure, to making us prepared for the rebound. We have accelerated the transformation of our organisation and this helps us work more efficiently and effectively together to create more value for our stakeholders and the planet.
Resources we use
People
Representing more than 100 nationalities and cultures, 48% of our employees are located in Europe, 18% in Asia and the Rest of the world, 24% in North America and 10% in Latin America. 8% work in Research & Innovation.
+23,000 Employees
24% of women
Financial
We have selectively invested €611 million of Capex from continuing operations in our growth businesses and €291 million to develop innovative sustainable solutions.
€5.4bn Equity attributable to Solvay share1
€4.1bn Underlying net debt
Naturalresources
Our energy costs represented €611 million. Excluding energy, the Group overall raw materials expenses amounted to circa €2.7 bn.
4,450KtRaw materials
103pjEnergy consumption
435Mm3Freshwater intake
How we
create value
Our G.R.O.W. strategy is aligned with global business trends that drive growth in our end-markets.
GMaterials
Unique high-performance polymers and composite technologies
Innovative solutions for cleaner mobility (lightweighting, batteries, CO2 and energy efficiency), electronics and healthcare.
31%
of Group EBITDA2
RChemicals
World leaders in essential chemicals for daily life
Chemical intermediates used in a broad range of applications in end-markets like Building, Industry, Healthcare, Personal and Home care, Feed and Food.
42%
of Group EBITDA2
OSolutions
Unique formulation & application expertise
Customized specialty formulations for surface chemistry & liquid behavior, maximizing yield and efficiency and minimizing environmental impact. Used in diverse markets like Agro, Food, Electronics, Consumer goods.
27%
of Group EBITDA2
WSolvay One
New operating model and culture
Customers are at the heart of our new more agile organization and performance-driven culture.
Where we create value
- Aerospace and Automotive
- Consumer goods, Home, Personal & Health care
- Resources & Environment
- Agro, Feed & Food
- Electronics
- Building
- Industrial applications
Value we create
Economic output
Environmental output
Social output
-
Economic output
€1.9bnUnderlying Ebitda
€0.9bnFCF to Solvay shareholders from continuing operations
€3.75 per shareDividend 2020 recommended3
€195MIncome taxes
473Core suppliers
-
Environmental output
10.1Mt CO2eq.Greenhouse gas emissions4
2KtAir emissions: Nitrogen oxides
2.9KtAir emissions: Sulfur oxides
27PJSolid fuels
107Pressure on biodiversity5
70KtNon-recoverable industrial waste
313Mm3Intake of freshwater
52%Net sales with sustainable solutions
5%Circular economy6
-
Social output
0.40 per million hours workedMedical Treatment Accident Rate7
24.6%Women in mid and senior management levels
16 weeksMaternity leave time open to all co-parents
€14.5MSpecial Covid bonus
€10.2MGlobal Performance Sharing Plan8
15%Employee turnover
€1.9MGroup donations
1 Excluding hydrid bonds
2 Excluding the contribution from corporate and business services,
3 Recommended to the Shareholders meeting on May 11, 2021,
4 (scope 1 & 2) at constant perimeter;
5 In number of animal or plant species potentially impacted in one year. ReCiPe method for biodiversity impact assessment,
6 Circular economy indicators are still in the development phase, in the frame of the Circulytics® approach, co-developed with the Ellen MacArthur Foundation;
7 Rate of accidents with medical treatment, with or without work stoppage; employees and contractors;
8 All employees worldwide S14 grade or below